Published in Eur Heart J on December 01, 2009
Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PLoS One (2011) 1.24
Detection of circulating platelet-monocyte complexes in persons infected with human immunodeficiency virus type-1. J Virol Methods (2012) 0.97
Interleukin-1 and acute brain injury. Front Cell Neurosci (2015) 0.95
The role of platelets in the recruitment of leukocytes during vascular disease. Platelets (2015) 0.87
Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation. Br J Clin Pharmacol (2011) 0.86
Central aortic pulse pressure, thrombogenicity and cardiovascular risk. J Thromb Thrombolysis (2017) 0.75
A case of haemorrhagic cystitis by inhaled salbutamol and salmeterol. Eur J Clin Pharmacol (2011) 0.75
Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study. Lancet (2008) 2.53
Plasma levels of receptor for advanced glycation end products, blood transfusion, and risk of primary graft dysfunction. Am J Respir Crit Care Med (2009) 2.43
Increased wave reflection rather than central arterial stiffness is the main determinant of raised pulse pressure in women and relates to mismatch in arterial dimensions: a twin study. J Am Coll Cardiol (2009) 2.06
Graft reconstruction of inferior vena cava for renal cell carcinoma stage pT3b or greater. Urology (2011) 1.80
Poor prescribing is continual. BMJ (2006) 1.55
Patients' preferences for the management of non-metastatic prostate cancer: discrete choice experiment. BMJ (2004) 1.54
Cerebral Autoregulation Monitoring with Ultrasound-Tagged Near-Infrared Spectroscopy in Cardiac Surgery Patients. Anesth Analg (2015) 1.52
Ethnic differences in arterial responses and inflammatory markers in Afro-Caribbean and Caucasian subjects. Arterioscler Thromb Vasc Biol (2005) 1.49
Hypertension associated with rhabdomyolysis. J Clin Hypertens (Greenwich) (2007) 1.47
Cardiac effects of amiloride and of enalapril in the spontaneously hypertensive rat. J Hypertens (2003) 1.41
Hypoxic pulmonary vasoconstriction: mechanisms and controversies. J Physiol (2005) 1.39
The lipid and non-lipid effects of statins. Pharmacol Ther (2003) 1.29
Monocyte-platelet interaction induces a pro-inflammatory phenotype in circulating monocytes. PLoS One (2011) 1.24
Elevated heart rate and atherosclerosis: an overview of the pathogenetic mechanisms. Int J Cardiol (2008) 1.23
Pharmacogenetics of aspirin resistance: a comprehensive systematic review. Br J Clin Pharmacol (2008) 1.18
The role of the chemokines MCP-1, GRO-alpha, IL-8 and their receptors in the adhesion of monocytic cells to human atherosclerotic plaques. Cytokine (2008) 1.16
Molecular basis of statin-associated myopathy. Atherosclerosis (2008) 1.16
The transient receptor potential vanilloid 1 (TRPV1) receptor protects against the onset of sepsis after endotoxin. FASEB J (2007) 1.14
Comparative pharmacokinetics and pharmacodynamics of platelet adenosine diphosphate receptor antagonists and their clinical implications. Clin Pharmacokinet (2012) 1.12
Impairment of vascular endothelial nitric oxide synthase activity by advanced glycation end products. FASEB J (2003) 1.12
Human Müller glia with stem cell characteristics differentiate into retinal ganglion cell (RGC) precursors in vitro and partially restore RGC function in vivo following transplantation. Stem Cells Transl Med (2012) 1.12
Pulse pressure is an age-independent predictor of stroke development after cardiac surgery. Hypertension (2007) 1.11
Nrf2/ARE regulated antioxidant gene expression in endothelial and smooth muscle cells in oxidative stress: implications for atherosclerosis and preeclampsia. Sheng Li Xue Bao (2007) 1.11
Superoxide constricts rat pulmonary arteries via Rho-kinase-mediated Ca(2+) sensitization. Free Radic Biol Med (2008) 1.10
Soluble p-selectin and the risk of primary graft dysfunction after lung transplantation. Chest (2009) 1.10
Severe deep neck space infections and mediastinitis of odontogenic origin: clinical relevance and implications for diagnosis and treatment. Acta Otolaryngol (2009) 1.09
Increased expression of integrin-linked kinase attenuates left ventricular remodeling and improves cardiac function after myocardial infarction. Circulation (2009) 1.08
Activation of endothelial nitric oxide synthase by dietary isoflavones: role of NO in Nrf2-mediated antioxidant gene expression. Cardiovasc Res (2007) 1.06
Platelet-derived nitric oxide signaling and regulation. Circ Res (2007) 1.06
RV functional imaging: 3-D echo-derived dynamic geometry and flow field simulations. Am J Physiol Heart Circ Physiol (2002) 1.03
Nitric oxide signalling in the regulation of cardiovascular and platelet function. Front Biosci (Landmark Ed) (2011) 1.02
A genetic variant c.553G > T in the apolipoprotein A5 gene is associated with an increased risk of coronary artery disease and altered triglyceride levels in a Chinese population. Atherosclerosis (2005) 1.02
Cardiovascular targets for estrogens and phytoestrogens: transcriptional regulation of nitric oxide synthase and antioxidant defense genes. Free Radic Biol Med (2007) 1.02
Ideal methodology to assess systemic blood pressure in patients with continuous-flow left ventricular assist devices. J Heart Lung Transplant (2010) 0.97
Epithelial cells promote fibroblast activation via IL-1alpha in systemic sclerosis. J Invest Dermatol (2010) 0.96
Diastolic right ventricular filling vortex in normal and volume overload states. Am J Physiol Heart Circ Physiol (2003) 0.96
Cerebral blood flow autoregulation is preserved after continuous-flow left ventricular assist device implantation. J Cardiothorac Vasc Anesth (2012) 0.94
Nitric oxide dysfunction in vascular endothelium and platelets: role in essential hypertension. J Hypertens (2009) 0.94
Worse clinical outcomes in acute myocardial infarction patients with type 2 diabetes mellitus: relevance to impaired endothelial progenitor cells mobilization. PLoS One (2012) 0.93
Platelet activation in essential hypertension: implications for antiplatelet treatment. Am J Hypertens (2010) 0.92
Potent and selective PPAR-alpha agonist LY518674 upregulates both ApoA-I production and catabolism in human subjects with the metabolic syndrome. Arterioscler Thromb Vasc Biol (2008) 0.92
A genetic variant of apolipoprotein M increases susceptibility to coronary artery disease in a Chinese population. Clin Exp Pharmacol Physiol (2007) 0.92
The genetics of aspirin resistance. Int J Clin Pract (2007) 0.90
Transplantation of photoreceptors derived from human Muller glia restore rod function in the P23H rat. Stem Cells Transl Med (2014) 0.90
Decreased mobilization of endothelial progenitor cells contributes to impaired neovascularization in diabetes. Clin Exp Pharmacol Physiol (2009) 0.89
Noninvasive MRI monitoring of the effect of interventions on endothelial permeability in murine atherosclerosis using an albumin-binding contrast agent. J Am Heart Assoc (2013) 0.89
An ongoing role of α-calcitonin gene-related peptide as part of a protective network against hypertension, vascular hypertrophy, and oxidative stress. Hypertension (2014) 0.89
Right ventricular diastolic relaxation in conscious dog models of pressure overload, volume overload, and ischemia. J Thorac Cardiovasc Surg (2002) 0.89
beta-Actin regulates platelet nitric oxide synthase 3 activity through interaction with heat shock protein 90. Proc Natl Acad Sci U S A (2007) 0.88
17Beta-oestradiol partially attenuates the inhibition of nitric oxide synthase-3 by advanced glycation end-products in human platelets. Clin Exp Pharmacol Physiol (2007) 0.88
Leiomyosarcoma of renal vein, initially resembling pheochromocytoma. Clin Exp Hypertens (2012) 0.88
Mechanisms underlying beta2-adrenoceptor-mediated nitric oxide generation by human umbilical vein endothelial cells. J Physiol (2006) 0.88
Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts. PLoS One (2013) 0.88
The PlA1/A2 polymorphism of glycoprotein IIIa in relation to efficacy of antiplatelet drugs: a systematic review and meta-analysis. Br J Clin Pharmacol (2014) 0.88
RV instantaneous intraventricular diastolic pressure and velocity distributions in normal and volume overload awake dog disease models. Am J Physiol Heart Circ Physiol (2003) 0.87
Aspirin acetylates nitric oxide synthase type 3 in platelets thereby increasing its activity. Cardiovasc Res (2009) 0.87
Pyridoxine inhibits endothelial NOS uncoupling induced by oxidized low-density lipoprotein via the PKCα signalling pathway in human umbilical vein endothelial cells. Br J Pharmacol (2012) 0.87
Syndecan-4 over-expression preserves cardiac function in a rat model of myocardial infarction. J Mol Cell Cardiol (2012) 0.87
Effect of pioglitazone on heart function and N-terminal pro-brain natriuretic peptide levels of patients with type 2 diabetes. Acta Diabetol (2007) 0.86
Current concepts of platelet activation: possibilities for therapeutic modulation of heterotypic vs. homotypic aggregation. Br J Clin Pharmacol (2011) 0.86
Hypoxic pulmonary vasoconstriction in the absence of pretone: essential role for intracellular Ca2+ release. J Physiol (2013) 0.86
beta-adrenoceptors and potassium channels. Naunyn Schmiedebergs Arch Pharmacol (2006) 0.86
Aspirin modifies nitric oxide synthase activity in platelets: effects of acute versus chronic aspirin treatment. Cardiovasc Res (2003) 0.85
Inhibition of human endothelial cell nitric oxide synthesis by advanced glycation end-products but not glucose: relevance to diabetes. Clin Sci (Lond) (2005) 0.85
Surgical management of primary aldosteronism. not everything that shines is gold. Clin Exp Hypertens (2011) 0.85
l-Tetrahydropalmatine, an active component of Corydalis yanhusuo W.T. Wang, protects against myocardial ischaemia-reperfusion injury in rats. PLoS One (2012) 0.85
Generation of neoantigenic epitopes after posttranslational modification of type II collagen by factors present within the inflamed joint. Arthritis Rheum (2005) 0.84
Treatment of hypertension in the elderly. N Engl J Med (2008) 0.84
Celastrol prevents atherosclerosis via inhibiting LOX-1 and oxidative stress. PLoS One (2013) 0.84
A panel of lung injury biomarkers enhances the definition of primary graft dysfunction (PGD) after lung transplantation. J Heart Lung Transplant (2012) 0.84
The vascular effects of metabolic impairment clusters in subjects of different ethnicities. Atherosclerosis (2007) 0.84
The platelet fibrinogen receptor: from megakaryocyte to the mortuary. JRSM Cardiovasc Dis (2012) 0.83
Sca-1+ cardiac progenitor cell therapy with cells overexpressing integrin-linked kinase improves cardiac function after myocardial infarction. Transplantation (2013) 0.83
Renal injury is associated with operative mortality after cardiac surgery for women and men. J Thorac Cardiovasc Surg (2010) 0.83
Right ventricular diastolic function in canine models of pressure overload, volume overload, and ischemia. Am J Physiol Heart Circ Physiol (2002) 0.83
Effects of beta-adrenoceptor stimulation on endothelial nitric-oxide synthase phosphorylation of human umbilical vein endothelial cells. Acta Pharmacol Sin (2003) 0.83
Direct renin inhibition with aliskiren protects against myocardial ischemia/reperfusion injury by activating nitric oxide synthase signaling in spontaneously hypertensive rats. J Am Heart Assoc (2014) 0.83
Increased expression of integrin-linked kinase improves cardiac function and decreases mortality in dilated cardiomyopathy model of rats. PLoS One (2012) 0.83
Age decreases nitric oxide synthesis and responsiveness in human platelets and increases formation of monocyte-platelet aggregates. Cardiovasc Res (2007) 0.82
The interaction of vasoactive substances during exercise modulates platelet aggregation in hypertension and coronary artery disease. BMC Cardiovasc Disord (2008) 0.82
Benefits from treatment and control of patients with resistant hypertension. Int J Hypertens (2010) 0.82
Sleepy nurses: are we willing to accept the challenge today? Nurs Adm Q (2007) 0.82
Amlodipine, but not verapamil or nifedipine, dilates rabbit femoral artery largely through a nitric oxide- and kinin-dependent mechanism. Br J Pharmacol (2002) 0.82
Reaction of carnosine with aged proteins: another protective process? Ann N Y Acad Sci (2002) 0.82
Increased platelet expression of glycoprotein IIIa following aspirin treatment in aspirin-resistant but not aspirin-sensitive subjects. Br J Clin Pharmacol (2014) 0.81
S-nitrosophytochelatins: investigation of the bioactivity of an oligopeptide nitric oxide delivery system. Biomacromolecules (2011) 0.81
Prevalence, awareness, treatment and control of hypertension in an elderly population in Greece. Rural Remote Health (2010) 0.81
Endothelial function and arterial compliance are not impaired in subjects with heart failure of non-ischemic origin. J Card Fail (2009) 0.81
Pyridoxine improves platelet nitric oxide synthase dysfunction induced by advanced glycation end products in vitro. Int J Vitam Nutr Res (2010) 0.81
Quantitative and qualitative 2D electrophoretic analysis of differentially expressed mitochondrial proteins from five mouse organs. Proteomics (2012) 0.81
Paralysis as first manifestation of primary aldosteronism. Nephrol Dial Transplant (2004) 0.81